AXXINOVAR
Live / Registered — Registered (as of 30 Jan 2024)
What this means for you
Registered since 30 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79371135
- Registration number
- 7292506
- Mark type
- Word mark
- Filed
- 22 Aug 2022
- Published for opposition
- 14 Nov 2023
- Registered
- 30 Jan 2024
- Attorney of record
- Louis J. Levy
Goods and services
- Class 005 — Pharmaceuticals: Medicinal and pharmaceutical preparations for use in the syndromic approach for treating pain, headache, fever, coughs, shock, dehydration, hypoglycemia, oral and dental conditions, gastrointestinal conditions, respiratory disease, obstetrical/gynecological conditions, cardiovascular disease, skin diseases, allergic reactions, musculo-skeletal and joint diseases, kidney and urological disorders, otolaryngological diseases, eye diseases, neurological system diseases, metabolic and endocrinological diseases, hematological diseases, malignant diseases, protozoal infections and conditions, sexually transmitted infections, HIV and other viral infections, nutritional disorders and poisoning; pharmaceutical preparations, namely, contraceptive preparations
- Class 035 — Advertising and business services: Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; providing advertising, marketing and promotional services for the pharmaceutical and medical products of others
- Class 042 — Scientific and technological services: Scientific and medical research and development in the fields of medicines, diagnostic aids and radio-pharmaceuticals for the treatment of pain, headaches, fevers, coughs, shock, dehydration, hypoglycemia, oral and dental conditions, gastrointestinal conditions, respiratory conditions, obstetrical/gynecological conditions and contraception, cardiovascular conditions, skin diseases and allergic reactions, musculo-skeletal and joint conditions, kidney and urological disorders, otolaryngological diseases, eye conditions, neurological conditions, metabolic and endorcinological conditions, hematological conditions, trauma and injuries, malignant disease conditions, malaria, tuberculosis, leprosy, sexually transmitted infections, HIV and other viral infections and conditions, protozoa infections and conditions, poisoning; medical research laboratory services; providing medical and veterinary research information in relation to all of the above; providing medical and scientific research information in the field of pharmaceuticals
Owner
- Jitesh Devendra, US
- Jitesh Devendra, US
- Jitesh Devendra, US
Prosecution history
- 08 Sept 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Sept 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Sept 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 May 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 01 May 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 01 May 2024 — FINAL DISPOSITION PROCESSED
- 30 Apr 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 30 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 14 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Nov 2023 — PUBLISHED FOR OPPOSITION
- 13 Nov 2023 — NOTIFICATION PROCESSED BY IB
- 25 Oct 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 25 Oct 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 25 Oct 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED